Replies to post #7339 on Cronos Group Inc (CRON)

[Jack Tripper99]

Great article, makes january look promising!

[FUNMAN]

Raymond James Reiterates “Outperform” Rating for Cronos Group (TSE:CRON)
Posted by Michael Baxter on Dec 24th, 2019

https://rivertonroll.com/news/2019/12/24/raymond-james-reiterates-outperform-rating-for-cronos-group-tsecron.html

These brokerage calls are pretty meaningless without the meat and potatoes that explain their reasoning. But their clients get the info. - FUNMAN

Raymond James reaffirmed their outperform rating on shares of Cronos Group (TSE:CRON) in a report released on Friday, BayStreet.CA reports. Raymond James currently has a C$12.00 price target on the stock.

CRON has been the topic of a number of other research reports. BMO Capital Markets raised Cronos Group from an underperform rating to a market perform rating and set a C$16.00 price target on the stock in a report on Thursday, September 5th. Jefferies Financial Group reduced their price objective on Cronos Group from C$15.00 to C$10.00 in a research note on Friday, October 11th. CIBC decreased their price objective on Cronos Group from C$20.00 to C$17.00 in a research report on Wednesday, November 13th. Canaccord Genuity decreased their price objective on Cronos Group from C$13.00 to C$12.00 in a research report on Wednesday, November 13th. Finally, Cowen lowered their target price on Cronos Group from C$21.00 to C$17.00 in a research note on Tuesday, September 3rd. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company. Cronos Group currently has a consensus rating of Hold and a consensus target price of C$17.22.

TSE CRON opened at C$9.23 on Friday. The firm’s fifty day moving average is C$9.41 and its two-hundred day moving average is C$14.65. Cronos Group has a one year low of C$7.97 and a one year high of C$32.95. The company has a debt-to-equity ratio of 0.49, a quick ratio of 3.33 and a current ratio of 3.45. The firm has a market cap of $3.16 billion and a PE ratio of 6.87.



About Cronos Group

Cronos Group Inc, formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations ?MMPR?. The firm typically invests in companies based in Canada.